Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults

NCT02153541 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Antipyrine-benzocaine otic solution
OTHER: Glycerin with Oxyquinoline Sulfate

Sponsor

Global United Pharmaceutical Corporation